💰SEC Considers Staking Proposal for Bitwise Ethereum ETF
The Securities and Exchange Commission is evaluating a proposed rule change by NYSE Arca to amend regulations governing the listing of the Bitwise Ethereum ETF, specifically to allow staking of ether. This order initiates proceedings to determine if the change meets federal securities standards, inviting public comments and feedback on the proposal.
Learn More📦FSIS Notice on Renewing Import Inspection Application Requirements
In accordance with the Paperwork Reduction Act of 1995 and Office of Management and Budget (OMB) regulations, FSIS is announcing its intention to renew an approved information collection regarding import inspection applications. The approval for this information collection will expire on December 31, 2025. FSIS is making no changes to the existing information collection.
Learn More💊FDA Seeks Comments on Drug Safety Technology Meeting Program
The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the Emerging Drug Safety Technology Meeting (EDSTM) Program.
Learn More🎨Cultural Significance of Culturally Significant Object Importation
Notice is hereby given of the following determinations: I hereby determine that certain objects being imported from abroad pursuant to agreements with their foreign owners or custodians for temporary display in the exhibition "The Honest Eye: Camille Pissarro's Impressionism" at the Denver Art Museum, Denver, Colorado, and at possible additional exhibitions or venues yet to be determined, are of cultural significance, and, further, that their temporary exhibition or display within the United States as aforementioned is in the national interest. I have ordered that Public Notice of these determinations be published in the Federal Register.
Learn More💉FDA Notice on Dermal Fillers Advisory Committee Meeting
The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee (the Committee). The general function of the Committee is to provide advice and recommendations to the Agency on FDA's regulatory issues. The meeting will be open to the public. FDA is establishing a docket for public comment on this document.
Learn More⚡Combined Notice of Filings for Wholesale Generators and Electric Rates
The Department of Energy's notice outlines various filings related to exempt wholesale generator status and electric rate analyses. It provides details about applicants, docket numbers, and deadlines for public comment, emphasizing the regulatory landscape affecting the energy sector. Interested parties can engage in the proceedings by following specified guidelines for interventions and comments.
Learn More🧬Government-Owned Inventions Available for Licensing
The invention listed below is owned by an agency of the U.S. Government and is available for licensing to achieve expeditious commercialization of results of federally funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.
Learn More🚧NEPA Regulation Revisions and Their Impact on Infrastructure Projects
FHWA, FRA, and FTA are publishing this interim final rule (IFR) to modify the regulations implementing the National Environmental Policy Act (NEPA) that apply to all three agencies to be consistent with the removal of regulations previously issued by the Council on Environmental Quality (CEQ), the amendments to NEPA included in the section of the Fiscal Responsibility Act of 2023 known as the Building United States Infrastructure through Limited Delays and Efficient Reviews (BUILDER) Act of 2023, and amendments regarding efficient environmental reviews included in the Infrastructure Investment and Jobs Act of 2021. This rule will become effective immediately while the agencies seek comment on what further changes may be appropriate.
Learn More💊Exclusive Patent License Notice for CAR Technology by NIH
The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the patents applications listed in the Supplementary Information section of this notice to Capstan Therapeutics, Inc. (Capstan), a company located in San Diego, California, the United States of America.
Learn More📑Change Order Accounting Regulation; Implications for Contractors
Under the provisions of the Paperwork Reduction Act, the Regulatory Secretariat Division has submitted to OMB a request to review and approve an extension and revision of a previously approved information collection requirement regarding change order accounting and notification of changes.
Learn More